Literature DB >> 20113357

An international multicenter association study of the serotonin transporter gene in persistent ADHD.

E T Landaas1, S Johansson, K K Jacobsen, M Ribasés, R Bosch, C Sánchez-Mora, C P Jacob, A Boreatti-Hümmer, S Kreiker, K-P Lesch, L A Kiemeney, J J S Kooij, C Kan, J K Buitelaar, S V Faraone, A Halmøy, J A Ramos-Quiroga, B Cormand, A Reif, B Franke, E Mick, P M Knappskog, J Haavik.   

Abstract

Attention deficit hyperactivity disorder (ADHD) is a common behavioral disorder affecting children and adults. It has been suggested that gene variants related to serotonin neurotransmission are associated with ADHD. We tested the functional promoter polymorphism 5-HTTLPR and seven single nucleotide polymorphisms in SLC6A4 for association with ADHD in 448 adult ADHD patients and 580 controls from Norway. Replication attempts were performed in a sample of 1454 Caucasian adult ADHD patients and 1302 controls from Germany, Spain, the Netherlands and USA, and a meta-analysis was performed also including a previously published adult ADHD study. We found an association between ADHD and rs140700 [odds ratio (OR ) = 0.67; P = 0.01] and the short (S) allele of the 5-HTTLPR (OR = 1.19; P = 0.06) in the Norwegian sample. Analysis of a possible gender effect suggested that the association might be restricted to females (rs140700: OR = 0.45; P = 0.00084). However, the meta-analysis of 1894 cases and 1878 controls could not confirm the association for rs140700 [OR = 0.85, 95% confidence interval (CI) = 0.67-1.09; P = 0.20]. For 5-HTTLPR, five of six samples showed a slight overrepresentation of the S allele in patients, but meta-analysis refuted a strong effect (OR = 1.10, 95% CI = 1.00-1.21; P = 0.06). Neither marker showed any evidence of differential effects for ADHD subtype, gender or symptoms of depression/anxiety. In conclusion, our results do not support a major role for SLC6A4 common variants in persistent ADHD, although a modest effect of the 5-HTTLPR and a role for rare variants cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20113357     DOI: 10.1111/j.1601-183X.2010.00567.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  18 in total

1.  The serotonin transporter gene polymorphism 5-HTTLPR moderates the effects of stress on attention-deficit/hyperactivity disorder.

Authors:  Dennis van der Meer; Catharina A Hartman; Jennifer Richards; Janita B Bralten; Barbara Franke; Jaap Oosterlaan; Dirk J Heslenfeld; Stephen V Faraone; Jan K Buitelaar; Pieter J Hoekstra
Journal:  J Child Psychol Psychiatry       Date:  2014-05-03       Impact factor: 8.982

Review 2.  Neuroinflammation as a risk factor for attention deficit hyperactivity disorder.

Authors:  Geoffrey A Dunn; Joel T Nigg; Elinor L Sullivan
Journal:  Pharmacol Biochem Behav       Date:  2019-05-16       Impact factor: 3.533

Review 3.  Common and specific genes and peripheral biomarkers in children and adults with attention-deficit/hyperactivity disorder.

Authors:  Cristian Bonvicini; Stephen V Faraone; Catia Scassellati
Journal:  World J Biol Psychiatry       Date:  2017-02-24       Impact factor: 4.132

4.  Epigenetics in Developmental Disorder: ADHD and Endophenotypes.

Authors:  Trevor Archer; Marlene Oscar-Berman; Kenneth Blum
Journal:  J Genet Syndr Gene Ther       Date:  2011-06-30

Review 5.  European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD.

Authors:  Sandra J J Kooij; Susanne Bejerot; Andrew Blackwell; Herve Caci; Miquel Casas-Brugué; Pieter J Carpentier; Dan Edvinsson; John Fayyad; Karin Foeken; Michael Fitzgerald; Veronique Gaillac; Ylva Ginsberg; Chantal Henry; Johanna Krause; Michael B Lensing; Iris Manor; Helmut Niederhofer; Carlos Nunes-Filipe; Martin D Ohlmeier; Pierre Oswald; Stefano Pallanti; Artemios Pehlivanidis; Josep A Ramos-Quiroga; Maria Rastam; Doris Ryffel-Rawak; Steven Stes; Philip Asherson
Journal:  BMC Psychiatry       Date:  2010-09-03       Impact factor: 3.630

6.  Attention-deficit hyperactivity disorder in patients with premature ejaculation: a pilot study.

Authors:  Hasan Soydan; Ferhat Ates; Cuneyt Adayener; Ilker Akyol; Umit Basar Semiz; Ercan Malkoc; Omer Yilmaz; Cengiz Basoglu; Kadir Vehbi Baykal
Journal:  Int Urol Nephrol       Date:  2012-09-22       Impact factor: 2.370

7.  Allele-specific associations of 5-HTTLPR/rs25531 with ADHD and autism spectrum disorder.

Authors:  Kenneth D Gadow; Carla J DeVincent; Victoria I Siegal; Doreen M Olvet; Saniya Kibria; Sarah F Kirsch; Eli Hatchwell
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-10-31       Impact factor: 5.067

8.  Common and rare alleles of the serotonin transporter gene, SLC6A4, associated with Tourette's disorder.

Authors:  Pablo R Moya; Jens R Wendland; Liza M Rubenstein; Kiara R Timpano; Gary A Heiman; Jay A Tischfield; Robert A King; Anne M Andrews; Samanda Ramamoorthy; Francis J McMahon; Dennis L Murphy
Journal:  Mov Disord       Date:  2013-04-29       Impact factor: 10.338

9.  A functional variant of the serotonin transporter gene (SLC6A4) moderates impulsive choice in attention-deficit/hyperactivity disorder boys and siblings.

Authors:  Edmund J S Sonuga-Barke; Robert Kumsta; Wolff Schlotz; Jessica Lasky-Su; Rafaela Marco; Ana Miranda; Fernando Mulas; Robert D Oades; Tobias Banaschewski; Ueli Mueller; Penny Andreou; Hanna Christiansen; Isabel Gabriels; Henrik Uebel; Jonna Kuntsi; Barbara Franke; Jan Buitelaar; Richard Ebstein; Michael Gill; Richard Anney; Herbert Roeyers; Aribert Rothenberger; Joseph Sergeant; Hans Christoph Steinhausen; Philip Asherson; Stephen V Faraone
Journal:  Biol Psychiatry       Date:  2011-04-17       Impact factor: 13.382

Review 10.  The genetics of attention deficit/hyperactivity disorder in adults, a review.

Authors:  B Franke; S V Faraone; P Asherson; J Buitelaar; C H D Bau; J A Ramos-Quiroga; E Mick; E H Grevet; S Johansson; J Haavik; K-P Lesch; B Cormand; A Reif
Journal:  Mol Psychiatry       Date:  2011-11-22       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.